Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 42 Issue 11, November 2021

NLRP3 inflammasome is implicated in inflammation-associated diseases such as multiple sclerosis. Liao et al. identified 1,2,4-TTB as a selective NLRP3 inflammasome inhibitor, which inhibited the aggregation of NLRP3 and ameliorated EAE progression and demyelination. This image illustrates the mechanism that 1,2,4-TTB inhibits NLRP3 inflammasome and the progression of EAE. See the article in pages 1769–1779.

Review Article

Top of page ⤴

Article

Top of page ⤴

Search

Quick links